microRNA in cardiovascular aging and age-related cardiovascular diseases

C de Lucia, K Komici, G Borghetti… - Frontiers in …, 2017 - frontiersin.org
Over the last decades, life expectancy has significantly increased although several chronic
diseases persist in the population, with aging as the leading risk factor. Despite …

A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well …

C Brown, M Mantzaris, E Nicolaou, G Karanasiou… - Cardio-Oncology, 2022 - Springer
Breast cancer patients are at a particularly high risk of cardiotoxicity from chemotherapy
having a detrimental effect on quality-of-life parameters and increasing the risk of mortality …

circRNA-miRNA-mRNA deregulated network in ischemic heart failure patients

A Madè, A Bibi, JM Garcia-Manteiga, AS Tascini… - Cells, 2023 - mdpi.com
Noncoding RNAs (ncRNAs), which include circular RNAs (circRNAs) and microRNAs
(miRNAs), regulate the development of cardiovascular diseases (CVD). Notably, circRNAs …

Dynamic regulation of SARS-Cov-2 binding and cell entry mechanisms in remodeled human ventricular myocardium

MR Bristow, LS Zisman, NL Altman, EM Gilbert… - Basic to translational …, 2020 - jacc.org
Using serial analysis of myocardial gene expression employing endomyocardial biopsy
starting material in a dilated cardiomyopathy cohort, we show that mRNA expression of the …

Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart

C Bär, S Chatterjee, I Falcão Pires… - Cardiovascular …, 2020 - academic.oup.com
Vast parts of mammalian genomes are actively transcribed, predominantly giving rise to non-
coding RNA (ncRNA) transcripts including microRNAs, long ncRNAs, and circular RNAs …

Novel therapies for prevention and early treatment of cardiomyopathies: now and in the future

GG Repetti, CN Toepfer, JG Seidman… - Circulation …, 2019 - Am Heart Assoc
Heritable cardiomyopathies are a class of heart diseases caused by variations in a number
of genetic loci. Genetic variants on one allele lead to either a degraded protein, which …

miR-208a in cardiac hypertrophy and remodeling

XH Huang, JL Li, XY Li, SX Wang, ZH Jiao… - Frontiers in …, 2021 - frontiersin.org
Various stresses, including pressure overload and myocardial stretch, can trigger cardiac
remodeling and result in heart diseases. The disorders are associated with high risk of …

[PDF][PDF] Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview

M Michalska-Kasiczak, A Bielecka-Dabrowa… - Archives of Medical …, 2018 - termedia.pl
The prevalence of heart failure with preserved ejection fraction (HFpEF) is steadily
increasing. Its diagnosis remains difficult and controversial and relies mostly on non …

Structural and functional phenotyping of the failing heart: is the left ventricular ejection fraction obsolete?

MR Bristow, DP Kao, KK Breathett, NL Altman… - JACC: Heart Failure, 2017 - jacc.org
Diagnosis, prognosis, treatment, and development of new therapies for diseases or
syndromes depend on a reliable means of identifying phenotypes associated with distinct …

MicroRNAs in heart failure, cardiac transplantation, and myocardial recovery: biomarkers with therapeutic potential

P Shah, MR Bristow, JD Port - Current heart failure reports, 2017 - Springer
Abstract Purpose of Review Heart failure is increasing in prevalence with a lack of recently
developed therapies that produce major beneficial effects on its associated mortality …